We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+13.56%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$608M
AUM Growth
+$63.9M
Cap. Flow
+$4.18M
Cap. Flow %
0.69%
Top 10 Hldgs %
38.67%
Holding
137
New
3
Increased
41
Reduced
18
Closed
2

Top Buys

Rank Stock Value
1
TWO.PRE
Two Harbors Investment Corp. 7.50% Series E Cumulative Redeemable Preferred Stock
TWO.PRE
+$1.71M
2
BGS icon
B&G Foods
BGS
+$773K
3
SLB icon
SLB Ltd
SLB
+$362K
4
CSCO icon
Cisco
CSCO
+$310K
5
WFC.PRL icon
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
+$275K

Top Sells

Rank Stock Value
1
CYS.PRB
CYS Investments, Inc.
CYS.PRB
+$1.54M
2
PYPL icon
PayPal
PYPL
+$188K
3
ROP icon
Roper Technologies
ROP
+$187K
4
BR icon
Broadridge
BR
+$185K
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$89K

Sector Composition

Rank Sector Weight
1 Technology 26.12%
2 Healthcare 19.22%
3 Financials 17.32%
4 Consumer Discretionary 9.09%
5 Communication Services 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
26
DELISTED
Allergan plc
AGN
$10.6M 1.75%
55,809
+385
+0.7% +$70.7K
REGN icon
27
Regeneron Pharmaceuticals
REGN
$83.2B
$10.4M 1.71%
25,660
+435
+2% +$166K
MRK icon
28
Merck
MRK
$325B
$9.86M 1.62%
145,682
+733
+0.5% +$46.7K
CRM icon
29
Salesforce
CRM
$161B
$9.14M 1.5%
57,475
+1,000
+2% +$148K
EW icon
30
Edwards Lifesciences
EW
$53.7B
$8.55M 1.41%
147,300
– –
CVX icon
31
Chevron
CVX
$383B
$8.35M 1.37%
68,300
-346
-0.5% -$42K
JPM icon
32
JPMorgan Chase
JPM
$960B
$7.9M 1.3%
70,010
+100
+0.1% +$11.4K
CSCO icon
33
Cisco
CSCO
$476B
$7.8M 1.28%
160,276
+6,900
+4% +$310K
GOOG icon
34
Alphabet (Google) Class C
GOOG
$4.29T
$7.07M 1.16%
118,540
-300
-0.3% -$18K
HAL icon
35
Halliburton
HAL
$28.2B
$5.62M 0.92%
138,550
-125
-0.1% -$5.17K
AMAT icon
36
Applied Materials
AMAT
$421B
$3.82M 0.63%
98,805
– –
AFL icon
37
Aflac
AFL
$60.8B
$3.37M 0.55%
71,618
+350
+0.5% +$16K
PG icon
38
Procter & Gamble
PG
$337B
$3.3M 0.54%
39,655
+200
+0.5% +$16.4K
GILD icon
39
Gilead Sciences
GILD
$168B
$2.37M 0.39%
30,705
+1,100
+4% +$83.1K
ABBV icon
40
AbbVie
ABBV
$440B
$2.37M 0.39%
25,045
– –
MMM icon
41
3M
MMM
$94.6B
$2.23M 0.37%
12,629
+918
+8% +$158K
VRTX icon
42
Vertex Pharmaceuticals
VRTX
$134B
$2.18M 0.36%
11,327
-500
-4% -$89K
WFC.PRL icon
43
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$2.17M 0.36%
1,690
+215
+15% +$275K
XOM icon
44
ExxonMobil
XOM
$657B
$1.93M 0.32%
22,695
+454
+2% +$37.1K
RDS.A
45
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.88M 0.31%
27,574
– –
BGS icon
46
B&G Foods
BGS
$276M
$1.73M 0.28%
63,000
+24,900
+65% +$773K
VZ icon
47
Verizon
VZ
$196B
$1.7M 0.28%
31,775
+1,100
+4% +$58.2K
TWO.PRE
48
DELISTED
Two Harbors Investment Corp. 7.50% Series E Cumulative Redeemable Preferred Stock
TWO.PRE
$1.68M 0.28%
+69,050
New +$1.71M
DD icon
49
DuPont de Nemours
DD
$19.5B
$1.45M 0.24%
8,914
– –
MSFT icon
50
Microsoft
MSFT
$3.74T
$1.15M 0.19%
10,072
+1,434
+17% +$155K
1
2
3 4 5

Similar funds

NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NI
NFC Investments Memphis, Tennessee $359M AUM 11.31% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
SWM
SK Wealth Management Providence, Rhode Island $360M AUM 14.81% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return

Kelly Lawrence W & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, Kelly Lawrence W & Associates held 137 positions worth $608M, up 12% from $544M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 3.6%. Kelly Lawrence W & Associates opened 3 new positions and exited 2, leaving the 137-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Kelly Lawrence W & Associates's largest Q3 2018 buy was Two Harbors Investment Corp. 7.50% Series E Cumulative Redeemable Preferred Stock: 69,050 shares worth $1.68M.
  • Kelly Lawrence W & Associates added most to B&G Foods in Q3 2018, an estimated $773K increase.
  • Kelly Lawrence W & Associates's biggest Q3 2018 reduction was PayPal, cutting an estimated $188K.
  • Kelly Lawrence W & Associates fully exited CYS Investments, Inc. in Q3 2018, selling an estimated $1.54M.
  • Kelly Lawrence W & Associates's ten largest holdings make up 39% of its $608M portfolio in Q3 2018.
  • Kelly Lawrence W & Associates opened 3 new positions and closed 2 in Q3 2018.
  • Kelly Lawrence W & Associates's portfolio value rose 12% quarter-over-quarter to $608M.

Based on Kelly Lawrence W & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.